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Background: The mortality of ruptured abdominal aortic aneurysm (rAAA) has decreased 3.5% per decade in the last 50
years to a current rate of 40%-50%. Reports have indicated that endovascular repair (EVAR) is feasible for rAAA and may
offer potential benefits over open repair. We examined the National Surgical Quality Improvement Program (NSQIP)
database to compare 30-day multicenter outcomes for EVAR vs open rAAA repair.
Methods: Patients that underwent rAAA repair in the NSQIP database from 2005 to 2007 were identified through a
combination of Current Procedural Terminology (CPT) codes and International Classification of Diseases-Ninth
Revision (ICD-9) diagnoses. Preoperative comorbidities, operative duration and transfusion, and 30 day outcomes were
evaluated using t tests or Chi-squared tests depending on the variable. A separate multivariable regression was performed
for each outcome adjusting for all independently predictive preoperative and intraoperative risk factors.
Results: A total of 427 patients were identified and 76.8% of patients underwent open repair. The open repair groups
exhibited lower albumin levels and higher percentage of patients with preoperative hematocrit (Hct) <38% and need for
preoperative ventilation. The requirement for preoperative blood transfusion was similar. Patients undergoing open
repair had much higher intraoperative transfusion requirements (11.8 8.9 vs 4.2 6.0 red blood cell units, P< .001).
After adjustment for preoperative mortality risk factors, the mortality risk was higher for open repair versus EVAR (odds
ratio 1.67, 95% confidence interval [CI] 0.91-3.05, P .096) but did not reach significance. After similar adjustment the
composite morbidity odds ratio for open repair versus EVAR was 1.82 (95% CI 1.11-2.99, P .018) and the pulmonary
adverse events odds ratio was 1.99 (95% CI 1.22-3.25, P  .006). Risks for the other outcomes were not significant.
Conclusions:Composite 30-day morbidity risk is lower after EVAR vs open repair of rAAA. Open repair is associated with
increased transfusion requirements. Performance of EVAR in rAAA patients with favorable anatomy could potentially
result in improved outcome as compared with open repair. ( J Vasc Surg 2010;51:305-9.)In recent years, the mortality of elective abdominal
aortic aneurysm (AAA) repair has been 5% or less, but once
rupture occurs, operative mortality is approximately 48%.1
Immediate postoperative death is usually the result of hem-
orrhagic shock; deaths occurring later are often due to the
multisystem organ failure and systemic inflammatory re-
sponse that develops even after technically successful aneu-
rysmorraphy.2 Case series and reports have demonstrated
that endovascular repair (EVAR) is feasible in the setting of
ruptured abdominal aortic aneurysm (rAAA),3,4 and may
offer a potential outcome benefit over open repair.5 It is
difficult to make true comparisons since most institutional
studies are not representative of the population at large.
The lower hemodynamic shifts and reduced physiologic
challenges associated with endovascular repair may confer a
survival benefit in ruptured aneurysm patients.6 We utilized
the National Surgical Quality Improvement Program
(NSQIP) database to examine the 30-daymortality and mor-
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though it is not possible to remove surgeon’s selection bias,
NSQIP is representative of community as well as academic
medical centers and contains preoperative comorbidities,
preoperative variables reflecting hemodynamic stability, in-
traoperative variables, and 30-day morbidity and mortality
outcomes.
METHODS
Study population. The American College of Sur-
geons (ACS) NSQIP is a robust reporting system designed
to provide reliable, risk-adjusted surgical outcomes data to
surgical services and administrators at medical centers
throughout the private sector so that surgical quality can be
assessed and improved on a national level.7-9 We analyzed
the data from the Participant Use Data File containing
vascular surgical cases submitted to the ACS NSQIP in
2005, 2006, and 2007 by 173 hospitals throughout the
United States. Veterans Administration NSQIP data was
not used for this study.
Data collection. The ACS NSQIP collects data on
135 variables, including preoperative risk factors, intraop-
erative variables, and 30-day postoperative morbidity and
mortality outcomes for patients undergoing surgical proce-
dures in both the inpatient and outpatient setting. Data are
prospectively collected in a standardized fashion according
to strict clinical definitions by dedicated surgical nurse
reviewers. Patients are followed throughout their hospital
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postoperatively. Nurse reviewers collect data from comput-
erized and paper patient medical records, doctor’s office
records, and telephone interviews with patients. The accu-
racy and reproducibility of the data have been previously
demonstrated.10 Patients in the database that underwent
repair of ruptured abdominal aortic aneurysm in the ACS
NSQIP database from 2005 to 2007 were identified by
a postoperative International Classification of Diseases-
Ninth Revision (ICD-9) diagnosis code of 441.3, “abdom-
inal aneurysm – ruptured” and by primary procedure Cur-
rent Procedural Terminology (CPT) codes. Repairs were
classified as either EVAR (CPT code 34800-34805) or
open (CPT code 35082 or 35103). To be included in the
database, patients had to survive long enough to undergo
an operation.
Analyses. Outcomes analyzed included 30-day mor-
tality and morbidity. Morbidities analyzed were pulmonary
adverse events (ventilation greater than 48 hours, un-
planned intubation, and/or postoperative pneumonia),
sepsis or septic shock, renal insufficiency or failure, surgical
site infection (superficial, deep, or organ/space), cardiac
arrest or infarction, and nervous system adverse events
(coma greater than 48 hours, peripheral nerve injury with
neurologic deficit, and/or stroke with neurologic deficit),
and composite morbidity (one or more of previously listed
morbidities plus wound dehiscence, urinary tract infection,
graft/prosthesis failure, bleeding requiring postoperative
transfusion, deep vein thrombosis, and/or pulmonary em-
bolism; all uniformly defined by the ACSNSQIP protocol).
Preoperative risks, operative variables and outcome
rates were compared by repair type using t tests or Chi-
squared tests, depending on the variable. A separate multi-
variable regression was performed for each outcome adjust-
ing for all independently predictive preoperative and
intraoperative risk factors. All of the over 55 ACS NSQIP
risk factors were considered for inclusion and entered via
forward stepwise regression (P for entry .05, exit .10).
Repair type (open versus EVAR) was then forced into the
final model.
RESULTS
The ACS NSQIP dataset from 173 hospitals contained
427 patients undergoing ruptured AAA repair in the years
2005 to 2007. The mean age was 73.3 9.6 years and 330
(77%) were male. There was no difference in history
of tobacco use, chronic obstructive pulmonary disease
(COPD), and coronary artery disease (CAD). More than
three-quarters (328; 76.8%) underwent open repair (Table
I). As indicators of preoperative hemodynamic status, we
report American Society of Anesthesiologists (ASA) status,
percentage of patients with hematocrit 38%, percentage
of patients requiring 4 units of preoperative blood trans-
fusion, preoperative renal failure, impaired sensorium,
coma, and preoperative ventilation within 48 hours of
surgery. As shown in Table I, there was higher percentage
of patients requiring preoperative ventilation and hemato-
crit 38% in the open repair group; also, preoperativealbumin was lower in these patients. The difference in the
requirement of preoperative blood transfusion was not
significant. Operative duration was similar (EVAR 195 
113 minutes vs open 203  90 minutes, P  .449) but
open repair resulted in much higher requirement for intra-
operative blood transfusion (EVAR 4.2 6.0 units vs open
11.8  8.9 units, P  .001).
Unadjusted mortality, composite morbidity, pulmo-
nary adverse events, and sepsis/septic shock were signifi-
cantly higher after open repair than EVAR (Chi-squared
P .05, Table II). The other outcome rates were all higher in
open repair patients, but not significantly so. Cardiac arrest
or infarct was twice as frequent after open repair (8.2%
versus 4.0%) but this was not statistically significant in this
sample of 427 patients. Independent ACS NSQIP preop-
erative risk factors for mortality in rAAA patients from
forward stepwise regression were ASA Class, preoperative
ventilation, age, severe COPD, do not resuscitate (DNR)
status, functional status, and white blood cell count 
4500/mm3 (Appendix, Table III). After adjustment for
these variables, the risk of mortality was higher for open
repair versus EVAR (odds ratio 1.67, 95% CI 0.91-3.05,
P .096) but did not reach significance. After similar adjust-
Table I. Demographics and select comorbidities in
patients undergoing EVAR versus open repair of ruptured
abdominal aortic aneurysms
Preoperative risk factor
EVAR
N  99
Open repair
N  328 P
Age (mean years  SD) 72.1  10.5 73.6  9.3 .167
Male (%) 79.8 76.5 .497
Smoking (%) 39.4 30.8 .111
COPD (%) 19.2 13.4 .156
Preop Albumin (mean g/dL
SD) (EVAR n 57, 58%;
Open n 186, 57%) 3.56  0.78 3.30  0.73 .017*
ASA Physical Status Class .169
ASA IV (%) 56.6 50.8
ASA V (%) 26.3 37.3
Hematocrit  38% (%) 44.4 59.5 .008*
Preop transfusion 4 u
PRBC’s (%) 2.0 6.1 .108
Preop. renal failure (%) 1.0 1.8 .575
Preop ventilation w/in 48 hr
of surgery (%) 9.1 19.2 .018*
Impaired sensorium (%) 7.1 12.5 .134
Preop coma (%) 4.0 6.1 .436
Immediate preop functional
status .059
Partially dependent (%) 14.1 15.5
Fully dependent (%) 23.2 34.8
Hx of angina, MI or CHF (%) 9.1 5.8 .246
Prior cardiac operation or
PCI (%) 27.3 21.3 .218
ASA, American Society of Anesthesiologists; CHF, congestive heart failure;
COPD, chronic obstructive pulmonary disease; EVAR, endovascular repair;
Hx, history; MI, myocardial infarction; PCI, percutaneous coronary inter-
vention; PRBC, packed red blood cells; Preop, preoperative.
P values are from Chi-squared test of differences (except age, which is a t
test).ment, the composite morbidity odds ratio for open repair
sus EV
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model in appendix Table IV) and the pulmonary adverse
events odds ratio was 1.99 (95% CI 1.22-3.25, P  .006,
model not shown). Risks for the other outcomes were not
significant (P  .05).
DISCUSSION
Elective endoluminal AAA repair has gained broad
acceptance, but it is not yet known to what extent rAAAs
are suitable for that approach. Mortality rates after EVAR
for rAAA vary from 11% to 45% in the literature.11,12 When
EVAR is performed selectively in patients who have favor-
able neck morphology and are not hemodynamically unsta-
ble, mortality as low as 8% has been observed.13 Using an
intention to treat by endovascular repair policy, Arya at al14
reported a mortality rate of 59% after open rAAA repair vs
39% after EVAR, similar findings were reported by Dalainas
et al.12 Cardiovascular instability has served as a selection
bias towards open repair and thus it is possible that EVAR
has been performed on patients with a greater chance of
survival.15 Nevertheless, EVAR has been shown to have less
of an adverse impact on patient physiology including the
cardiac, respiratory, and renal systems as well as reduced
inflammatory response.16,17 Furthermore, the potential for
venous injuries from dissection of the aortic neck is signif-
icant in the presence of a retroperitoneal hematoma or free
rupture;18 this is circumvented with an endoluminal ap-
proach. The physiologic trauma and the hemodynamic
shifts of EVAR are less than that of an open repair but there
is no high level evidence in favor of either approach.19
A study based on 43,033 Medicare beneficiaries
showed a survival benefit of EVAR vs open repair; this was
correlated with increasing annual surgeon and hospital
volume in both open and endoluminal aneurysm repair and
rAAA experience.20 This benefit was not confirmed by
Table II. Unadjusted and risk-adjusted outcomes by type
aneurysms
30-day outcome EVAR (n  99)
Ope
(n
Mortality (%) 22.2 3
Composite morbidity1 (%) 45.5 6
Pulmonary adverse events2 (%) 34.3 5
Sepsis/septic shock (%) 19.2 2
Renal insufficiency/ failure (%) 18.2 2
Surgical site infection3 (%) 5.1
Cardiac arrest or infarction (%) 4.0
Nervous system adverse events4 (%) 2.0
CI, Confidence interval; EVAR, endovascular repair; OR, odds ratio.
1Composite morbidity included patients experiencing one or more of 21 a
Program (NSQIP) protocol.
2Pulmonary adverse events included postoperative pneumonia, unplanned r
3Surgical site infections included superficial deep or organ/space surgical si
4Nervous system adverse events included peripheral nerve injury with neuro
5For each of the outcome logistic regressions, all of the over 55 NSQIP ri
stepwise regression. (P for entry .05, exit .10). Repair type (open ver
morbidity models are shown in the appendix.recent comparative studies in the community and universitysettings.21-23 Often, limiting factors for performance of
EVAR are lack of trained personnel as well as equipment
and grafts. Mehta et al5 stressed the importance of estab-
lishing a multidisciplinary protocol ensuring availability of
staff with experience in endoluminal procedures in the
operating room and adequate equipment. Using this stan-
dardized protocol, they achieved a mortality rate of 18%
with emergent endovascular repair of hemodynamically
stable and unstable patients. Hemodynamic instability does
not necessarily preclude EVAR as permissive hypotension
may reduce hemorrhage,24 and intraaortic balloon occlu-
sion can be used for endoluminal control of aortic rup-
ture.25,26
In the present study, mortality after open repair was
significantly higher; this difference did not persist after
adjustment for independent preoperative mortality risk fac-
tors. The adjusted mortality risk ratio of 1.67 favored
EVAR. Pulmonary adverse event rate and composite mor-
bidity was higher after open repair; Greco et al27 have also
found a lower rate of postoperative complications after
EVAR. Similarly, the requirement for intraoperative blood
transfusions was significantly higher for open repair; this
has been reported by other investigators as well.28,29 Re-
duced need for blood transfusion may be associated with
better outcome since several groups have demonstrated
that patients receiving allogeneic transfusions have had
higher mortality rates, higher risk of ICU admission, longer
hospital and ICU stays, higher postoperative infection
rates, higher risk of developing ARDS, longer time to
ambulation, higher incidence of atrial fibrillation, and
higher risk of ischemic outcomes compared with nontrans-
fused cohorts.30-35 There was a higher percentage of pa-
tients with preoperative hematocrit 38% among patients
undergoing open repair but the need for preoperative
pair in patients with ruptured abdominal aortic
ir
) Chi-squared P
Risk adjusted5 OR open
repair vs EVAR (95% CI) Wald P
.003* 1.67 (0.91-3.05) .096
.003* 1.82 (1.11-2.99) .018*
.006* 1.99 (1.22-3.25) .006*
.037* 1.60 (0.88-2.89) .118
.624 1.26 (0.69-2.30) .456
.255 2.01 (0.71-5.72) .190
.159 2.56 (0.73-9.0) .144
.181 2.40 (0.53-10.86) .257
events uniformly defined by the National Surgical Quality Improvement
ation and/or ventilation longer than 48 hours.
ctions.
deficit, stroke with neurologic deficit, and/or coma greater than 48 hours.
ors were considered for inclusion and entered into the model via forward
AR) was then forced into the final model. The mortality and compositeof re
n repa
 328
7.2
2.5
0.0
9.9
0.4
8.5
8.2
5.2
dverse
eintub
te infe
logic
sk facttransfusion was not significantly different.
JOURNAL OF VASCULAR SURGERY
February 2010308 Davenport et alSerum albumin has been shown to be a significant
predictor of postoperative morbidity and mortality;36-37
patients undergoing open repair in our study had signifi-
cantly lower pre-procedure albumin levels indicating worse
physiologic status as compared with the patients that un-
derwent EVAR. This, in addition to the higher percentage
of patients with hematocrit 38%, may be at least partially
responsible for the better outcomes observed in the EVAR
group, since the patient population with relatively reduced
reserves underwent an open procedure with major physio-
logic impact.
Our study represents a retrospective review, and sur-
geon preference determined treatment method thus intro-
ducing selection bias. In addition, preoperative hemody-
namic parameters and morphologic characteristics of the
aneurysms to determine anatomic suitability of an endolu-
minal approach are not available in the NSQIP database.
We used several markers that reflect preoperative hemody-
namic status to address this limitation. Furthermore, per-
qutaneous balloon occlusion of the suprarenal aorta ren-
ders EVAR feasible even in the presence of hemodynamic
instability. Timaran et al38 reported that with the use of
endografts with body diameter up to 36 mm, more than
63% of aneurysms are suitable for EVAR regardless of
patient age, fitness, or aneurysm size. In the Amsterdam
Acute Aneurysm Trial,39 the anatomy of the aorta and iliac
arteries was considered appropriate for endovascular repair
in 45.8% of the patients. Similarly, Slater et al40 found that
49% of the patients treated for rAAA in a tertiary academic
center would have been anatomic candidates for EVAR,
and a feasibility rate of 59% has been reported by Hassen-
Khodia et al.4 Lesperance et al41 analyzed the Nationwide
Inpatient Sample and reported increase in use of EVAR for
rAAA from 6% in 2001 to 11% in 2004; a significant
mortality benefit was seen with EVAR at teaching hospitals,
whereas in non-teaching facilities, EVAR carried a higher
risk of in-hospital death. Therefore, there appears to be
increasing use of EVAR for rAAA since the beginning of the
decade, but during the last two years of our study the
utilization of this method has reached a plateau as it was
applied to approximately one-quarter of the patients.
In conclusion, our data indicate that EVAR confers a
morbidity benefit for rAAA as well as a trend towards
improved mortality. The literature suggests that 45% or
more of rAAA patients should be anatomic candidates for
EVAR; this implies underutilization of this method in the
NSQIP population. Performance of EVAR in rAAA pa-
tients with favorable anatomy could potentially result in
lower morbidity and decreased transfusion requirements as
compared with open repair. Further studies are necessary to
determine if more widespread use of EVAR bestows a
survival benefit to these critically ill patients.
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making precise estimation of the odds ratio impossible in this dataset. It is
clearly a high risk factor.
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model in patients undergoing repair for ruptured abdominal
aortic aneurysm (N 426)
Mortality logistic regression model in ruptured AAA repair
patients
Model Chi-squared P  .001, H-L statistic 8.4 P  .391,
c-index  0.82
Odds
ratio Sig.
95% CI for OR
Lower Upper
Open Repair vs EVAR 1.668 .096 .913 3.046
ASA Physical Status Class
vs 1-3 .000
ASA 4 3.018 .051 .996 9.149
ASA 5 10.068 .000 3.263 31.065
Preoperative ventilation 2.446 .015 1.190 5.028
Age (per year from
mean) 1.040 .004 1.013 1.067
History of COPD 2.478 .006 1.298 4.732
DNR Status 9.463 .048 1.020 87.824
Functional status vs
independent .038
Partially dependent .556 .143 .253 1.221
Fully dependent 1.667 .092 .920 3.019
WBC  4500 5.880 .061 .924 37.414
ASA, American Society of Anesthesiologists; CI, confidence interval;
COPD, chronic obstructive pulmonary disease; DNR, do not resuscitate;
EVAR, endovascular repair; OR, odds ratio; WBC, white blood cells.Table IV (online only). Morbidity logistic regression
model in patients undergoing repair for ruptured
abdominal aortic aneurysm (N  426)
Morbidity logistic regression model in ruptured AAA repair
patients
Model Chi-squared P  .001, H-L statistic 15.1 P  .057,
c-index  0.72
Odds
ratio Sig.
95% CI for
OR
Lower Upper
Open repair vs EVAR 1.821 .018 1.110 2.985
Age (per year from mean) 1.035 .003 1.012 1.059
Steroid treatment for chronic
condition .284 .025 .094 .856
Sodium  135 .442 .007 .244 .800
Hematocrit  38% 1.938 .004 1.233 3.046
Preop coma .398 .073 .146 1.089
Preop renal failure  10* .999 .000 .
Functional status vs
independent .004
Partially dependent 1.757 .071 .953 3.238
Fully dependent 2.594 .002 1.419 4.740
Preop ventilation .366 .009 .173 .776
Hematocrit  45% 3.019 .019 1.201 7.585
CI, Confidence interval; EVAR, endovascular repair; OR, odds ratio; Preop,
preoperative.
*All seven patients with preoperative renal failure experienced morbidity
